GSK2248761 (14C-labeled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2248761 (14C-labeled), covering 2014-05-19 to 2014-05-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult Subjects [Phase 1]